PROTHENA CORPORATION PLC - ORDINARY SHARES

8.5000

02-May-25 16:45:00

15 minutes delayed

Stocks

-0.2200

-2.52%

Today's range

8.2500 - 9.5000

ISIN

N/A

Source

NASDAQ

Prothena to Hold Investor Webcast to Review Three Oral Presentations from AD/PD 2021

08 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
Prothena Announces Promising New Preclinical and Clinical Data from its Neurodegenerative Programs Selected for Oral Presentations at AD/PD 2021

24 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
Prothena Reports Fourth Quarter and Full Year 2020 Financial Results, and Provides Financial Guidance and R&D Update

11 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

05 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
Prothena to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast Conference Call on February 11th

04 Feb 2021 16:05:00 By Nasdaq GlobeNewswire
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA

01 Feb 2021 16:15:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.